153756-68-4

Usage

InChI:InChI=1/C15H27NO10/c1-5-9(19)11(21)12(22)15(24-5)26-13-7(4-17)25-14(23-3)8(10(13)20)16-6(2)18/h5,7-15,17,19-22H,4H2,1-3H3,(H,16,18)/t5-,7-,8-,9+,10-,11+,12-,13-,14-,15-/m1/s1

Upstream product

• 152501-24-1 methyl O-(2,3,4-tri-O-acetyl-6-deoxy-β-D-galactopyranosyl)-(1<*>4)-3,6-di-O-acetyl-2-acetamido-2-deoxy-β-D-glucopyranoside 
• 68774-39-0 methyl O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-(1<*>4)-2-acetamido-3,6-di-O-acetyl-2-deoxy-β-D-glucopyranoside 
• 152501-19-4 methyl O-(4,6-O-benzylidene-2,3-di-O-acetyl-β-D-galactopyranosyl)-(1<*>4)-3,6-di-O-acetyl-2-acetamido-2-deoxy-β-D-glucopyranoside 
• 152501-23-0 methyl O-(2,3,4-tri-O-acetyl-6-O-p-toluenesulfonyl-β-D-galactopyranosyl)-(1<*>4)-3,6-di-O-acetyl-2-acetamido-2-deoxy-β-D-glucopyranoside 
• 152501-21-8 methyl O-(2,3,4-tri-O-acetyl-6-O-tert-butyldimethylsilyl-β-D-galactopyranosyl)-(1<*>4)-3,6-di-O-acetyl-2-acetamido-2-deoxy-β-D-glucopyranoside 
• 152501-22-9 methyl O-(2,3,4-tri-O-acetyl-β-D-galactopyranosyl)-(1<*>4)-3,6-di-O-acetyl-2-acetamido-2-deoxy-β-D-glucopyranoside 
• 152501-20-7 methyl O-(2,3-di-O-acetyl-β-D-galactopyranosyl)-(1<*>4)-3,6-di-O-acetyl-2-acetamido-2-deoxy-β-D-glucopyranoside 
• 91852-13-0 methyl O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-(1<*>4)-3,6-di-O-acetyl-2-azido-2-deoxy-β-D-glucopyranoside 
• 68774-40-3 N-acetyllactosamine methyl glycoside 
• 131545-07-8 Methyl 2-acetamido-3,6-di-O-acetyl-2-deoxy-4-O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-β-D-glucopyranoside 
• 131545-05-6 Ethyl 3,6-di-O-acetyl-2-deoxy-2-phthalimido-1-thio-4-O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-β-D-glucopyranoside 
• 131545-06-7 Methyl 3,6-di-O-acetyl-2-deoxy-2-phthalimido-4-O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-β-D-glucopyranoside 

Relevant academic research and scientific papers

Characterization of inhibitory activities and binding mode of synthetic 6'-modified methyl N-acetyl-β-lactosaminide toward rat liver CMP-D-Neu5Ac: D-galactoside-(2->6)-α-D-sialyltransferase

6'-Deoxy (12), 6'-thio (13), and 6'-O-tetrahydropyranosyl (14) analogues of methyl N-acetyl-β-lactosaminide (3), were synthesized from lactose.NOE experiments proved that they adopt the same conformation as that of 3.Inhibition studies using these synthet

Improved Synthesis of α-L-Fuc(1->4)-β-D-GlcNAc and α-L-Fuc(1->6)-β-D-GlcNAc Building Blocks: A Convergent Strategy Employing 4-O->6-O Acetyl Migration; NOE Data of the Protected α-1,4-Linked Disaccharide

The synthesis of the two ethylthio disaccharide building blocks 10 and 17 was achieved by coupling of fucosyl bromide 9 with the acceptor alcohols 6 and 7 under in situ anomerization conditions.The selectively protected 2-deoxy-2-phthalimidoglucose derivative 7 was derived from 6 by utilizing an optimized acetyl migration reaction.The ethylthio function in disaccharides 10 and 17 was activated with bromine, and excess bromine was removed with cyclohexene.The sensitive 1,6-linkage in the disaccharide 10 proved to be stable under these activating conditions.The disaccharide bromides 11 and 18 were treated with methanol to afford after deblocking the methyl glycosides 16 and 23.Homonuclear 1H-NOE data were obtained for the protected 1,4-linked disaccharide 17 suggesting that its preferred solution conformation is rather similar to the solution conformation of the deblocked disaccharide 23 in aqueous solution as known from literature data.Key Words: Oligosaccharide synthesis / Thioglycosides / Acetyl migration / Glycosidic linkage conformation / Carbohydrates